TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
45 hedge funds and large institutions have $23.4M invested in TFF Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
59% more call options, than puts
Call options by funds: $1.08M | Put options by funds: $676K
5% more funds holding
Funds holding: 43 → 45 (+2)
13% less capital invested
Capital invested by funds: $26.8M → $23.4M (-$3.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$545K |
| 2 |
GS
Gagnon Securities
New York
|
+$175K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$109K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$91K |
| 5 |
QPW
Quantum Private Wealth
Tampa,
Florida
|
+$61.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$741K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$110K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$65.4K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$59K |
TFFP Hedge Fund Activity: Q2 2022 in Review
45 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q2 2022, worth a combined $23.4M — down 13% from $26.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TFFP positions and 3 closed out — a net gain of 2 holders — while 16 added to existing stakes and 8 trimmed.
The largest buyer was Sepio Capital, opening a new position worth an estimated $545K. The largest seller was Janney Montgomery Scott, exiting entirely with an estimated $1M sold.
- 45 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q2 2022, up from 43 in Q1 2022.
- Funds reported $23.4M of TFF Pharmaceuticals, Inc. Common Stock stock for Q2 2022, down 13% quarter-over-quarter.
- 5 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of +2 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q2 2022 was Sepio Capital, an estimated $545K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q2 2022 was Janney Montgomery Scott, an estimated $1M sold.
Based on aggregated 13F filings for Q2 2022.